Confusional Arousals Market By Cause (Sleep Apnea-Associated, Anxiety-Related, Medication-Induced, Neurological Conditions, Idiopathic), By Diagnosis Method (Polysomnography, Clinical Evaluation, Home Sleep Testing Devices), By Type of Treatment (Pharmacological Treatment, Non-Pharmacological Treatment), By Technology (Wearable Sleep Trackers, EEG-based Monitoring Devices, Smartphone Apps and Digital Platforms, AI-based Sleep Analytics Tools), By End User (Hospitals & Sleep Clinics, Homecare Settings, Specialty Clinics, Research Institutes, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

---

Report Coverage:

By Cause

• Sleep Apnea-Associated
• Anxiety-Related
• Medication-Induced
• Neurological Conditions
• Idiopathic

By Diagnosis Method

• Polysomnography
• Clinical Evaluation
• Home Sleep Testing Devices

By Type of Treatment

• Pharmacological Treatment
• Non-Pharmacological Treatment

By Technology

• Wearable Sleep Trackers
• EEG-based Monitoring Devices
• Smartphone Apps and Digital Platforms
• AI-based Sleep Analytics Tools

By End User

• Hospitals & Sleep Clinics
• Homecare Settings
• Specialty Clinics
• Research Institutes
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• Jazz Pharmaceuticals
• Eisai Co., Ltd.
• Takeda Pharmaceutical Company
• Pfizer Inc.
• Sanofi S.A.
• ResMed Inc.
• Philips Respironics
• Natus Medical Incorporated
• Compumedics Limited
• Somnomedics GmbH
• Fitbit
• Apple Inc.
• Oura Health Ltd.
• Withings
• Eight Sleep